About 200 reports

Prostate Cancer:

  • Prostate Cancer
  • World
  • Cancer Incidence
  • Cancer Mortality

##.## Rising Prevalence of Prostate Cancer

  • Prostate Cancer
  • Diagnostics
  • United States
  • Diagnostic Imaging Density
  • Diagnostic Revenue

"US Prostate Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • US Prostate Cancer Drug Market Opportunity: > US$ 4 Billion • Comprehensive Clinical Insight On 25 FDA Approved Prostate Cancer Drugs • Drug Dosage, Patent, Price, Patent Insight • Insight On 222...

  • Prostate Cancer
  • United States
  • World
  • Mortality Rate

Castrate Resistant Prostate Cancer Therapeutics Market Report Overview Castrate Resistant Prostate Cancer Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Castrate Resistant Prostate Cancer Therapeutics market types and...

  • Prostate Cancer
  • World
  • Health Provider Density

The Global Castrate-resistant Prostate Cancer Market size is expected to reach $14.5 billion by 2026, rising at a market growth of 8.3% CAGR during the forecast period. Castrate-resistant Prostate Cancer (CRPC), a variety of prostate cancer that generally recurs after managing androgen deprivation therapy (ADC), is getting prominent in the...

  • Prostate Cancer
  • World
  • APAC
  • Asia
  • North America
  • Drug Approval

“Prostate Cancer Vaccines - Competitive Intelligence Analysis, 2019” report outlays comprehensive insights of present scenario and growth prospects across Prostate Cancer Vaccines. A detailed picture of the pipeline landscape is provided along with respective companies’ overview with summation of data from multiple sources and complete analysis...

  • Prostate Cancer
  • World
  • United States

Table ##: Lectin-Nanoparticle Biomarker - Prostate Cancer - Prostate Cancer Screening Trial

  • Prostate Cancer
  • Clinical Trial
  • United States
  • World
  • United Kingdom
  • Health Provider Density
  • Medical Technology Density

Castrate-resistant Prostate Cancer Market Size, Share & Trends Analysis Report By Therapy (Chemotherapy, Hormonal Therapy, Immunotherapy, Radiotherapy), By Region, And Segment Forecasts, 2020 - 2027 Castrate-resistant Prostate Cancer Market Growth & Trends The global castrate-resistant prostate...

  • Prostate Cancer
  • World
  • APAC
  • Europe
  • United States
  • Health Expenditure

"Metastatic Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Metastatic Prostate Cancer. The marketed products information covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further...

  • Prostate Cancer
  • World
  • United States
  • Health Expenditure

"Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Metastatic Hormone Refractory Prostate Cancer. The marketed products information covers their product details, patents (US & EU), historical and...

  • Prostate Cancer
  • World
  • United States
  • Health Expenditure

This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Million by the following Segments: Hormone Therapy, and Other Therapies. The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period...

  • Prostate Cancer
  • Hormone
  • World

Prostate Cancer Therapeutics Market - Scope of the Study [206 Pages Report] the analyst (PMR) carried out a comprehensive analysis measuring the growth potential of the prostate cancer therapeutics market in its latest research report for the forecast period of 2019-2027. The business study encompasses some key insights...

  • Prostate Cancer
  • World

The ongoing clinical trial research report- “2019 Metastatic Prostate Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Metastatic Prostate Cancer trials across the world. The report presents top level analysis of global Metastatic Prostate Cancer clinical trials across countries, companies and universities....

  • Prostate Cancer
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Hormone-Sensitive Prostate Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Hormone-Sensitive Prostate Cancer trials across the world. The report presents top level analysis of global Hormone-Sensitive Prostate Cancer clinical trials across countries, companies...

  • Prostate Cancer
  • Clinical Trial
  • World
  • APAC

‘Hot Flashes Associated with Prostate Cancer Treatment—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Hot Flashes Associated with Prostate Cancer Treatment in the United States, EU5 (Germany, Spain, Italy,...

  • Prostate Cancer
  • United States
  • Spain
  • France
  • Japan
  • Germany
  • Italy

HIGH COST OF PROSTATE CANCER DRUGS

  • Prostate Cancer
  • Therapy
  • World
  • Cancer Mortality
  • Health Expenditure

The ongoing clinical trial research report- “2019 Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer trials across the world. The report presents top level analysis...

  • Prostate Cancer
  • Clinical Trial
  • Hormone
  • World
  • APAC

The ongoing clinical trial research report- “2019 Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer trials across the world. The report...

  • Prostate Cancer
  • Clinical Trial
  • Hormone
  • World
  • APAC

Cellular Immunotherapy to Target PSA for Prostate Cancer – Drug Profile

  • Prostate Cancer
  • World
  • Northern Europe
  • Drug Approval
  • Lead Price

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 6 - Influencer Pool: 922 - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....

  • Prostate Cancer
  • Diagnostics
  • World

U.S. Prostate Cancer Treatment Device Market Research Report: By Type (Radiation, Surgery, High-Intensity Focused Ultrasound, Cryotherapy), End User (Hospitals, Specialty Centers) - Industry Analysis and Growth Forecast to 2030 The U.S. prostate cancer treatment devices market attained a value of $95.9 million in 2019...

  • Prostate Cancer
  • Healthcare
  • United States
  • Health Expenditure

Vaccine to Target PSMA and TARP for Prostate Cancer – Drug Profile

  • Prostate Cancer
  • Pharmaceutical
  • Renal Cancer
  • World
  • Pharmaceutical Registrations

Small Molecules to Inhibit CYP## for Prostate Cancer – Drug Profile

  • Prostate Cancer
  • World
  • Cancer Mortality
  • Drug Approval

Prostate Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Preliminary, Confirmatory (PCA3, Trans-rectal Ultrasound, Biopsy)), By Region, And Segment Forecasts, 2020 - 2027 The global prostate cancer diagnostics market size is expected to reach USD 7.65 billion by 2027, registering a CAGR...

  • Prostate Cancer
  • World
  • North America
  • United States

Small Molecules to Inhibit CYP## for Prostate Cancer – Drug Profile

  • Prostate Cancer
  • World
  • Cancer Mortality
  • Drug Approval

Prostate Cancer Treatment Market by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others) and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global prostate cancer treatment market...

  • Prostate Cancer
  • World
  • APAC
  • Europe

Marketed (phase ## in prostate cancer)

  • Prostate Cancer
  • World
  • Health Expenditure
  • Drug Approval

Small Molecule to Inhibit PI##K for Prostate Cancer – Drug Profile

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

Small Molecule to Inhibit PI##K for Prostate Cancer – Drug Profile

  • Therapy
  • Prostate Cancer
  • Ovarian Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

“Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET, prostate cancer and other diseases. The report covers marketed products details and also drugs that are in various phases of development (Discovery, Preclinical & Clinical)....

  • Prostate Cancer
  • World